Director

profile_image
Prof. Dr. Tanja Weil
Director
Email:weil@...

Group News

Tanja Weil to visit at the CMSE (Center for Macromolecular Science and Engineering)/University of Florida for the 2017 Macrocenter Presentation Series.

Prof. Kenneth B. Wagener and Prof. T. Weil (Febr. 2017)

Tanja Weil to visit at the CMSE (Center for Macromolecular Science and Engineering)/University of Florida for the 2017 Macrocenter Presentation Series.

We are very pleased to announce the acceptance of a new manuscript in ACS Nano.

"Diverse Applications of Nanomedicine"

Congratulation to the authors!

The paper "NIR-emitting and Photo-thermal Active Nanogold as Mitochondria-Specific Probes" was accepted in Biomaterials Science

Many thanks to Sabya and Yuzhou for their excellent work!

ACS Macro Lett.2017, 6, 241-246
© 2017 American Chemical Society
Many thanks to Andi, Chaojian, Yu and David for their excellent work!

The paper “Synthesis of Peptide-Functionalized Poly(bis-sulfone) Copolymers Regulating HIV-1 Entry and Cancer Stem Cell Migration” is online accessible in ACS Macro Letters.

ACS Macro Lett.2017, 6, 241-246

© 2017 American Chemical Society

Many thanks to Andi, Chaojian, Yu and David for their excellent work!

J. Am. Chem. Soc. 139, 6, 2512 (2017) © American Chemical SocietyCongratulations to Sabya, Bikram and Stephan for their excellent work!

Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications

J. Am. Chem. Soc. 139, 6, 2512 (2017)
© American Chemical Society

Congratulations to Sabya, Bikram and Stephan for their excellent work!

Department Weil

Synthesis of Macromolecules

The department “Synthesis of Macromolecules” develops tailored nanomaterials for biomedical and materials science applications. It also designs and synthesizes precision macromolecules and hybrid materials that can, for example, enhance the uptake of viruses into stem cells thus offering great opportunities to improve gene therapy.

The HYPERDIAMOND project was selected as one of the eight projects (out of 390) in the Horizon 2020 call Personalizing Health and Care: Development of new diagnostic tools and technologies. It is aiming at developing a new technology for improving medical imaging in vivo based on hyperpolarized diamond.



Horizon2020 “Hyperdiamond”

M. Wagner, Y. Wu, T. Weil


The HYPERDIAMOND project was selected as one of the eight projects (out of 390) in the Horizon 2020 call Personalizing Health and Care: Development of new diagnostic tools and technologies. It is aiming at developing a new technology for improving medical imaging in vivo based on hyperpolarized diamond.

BIOQ will create novel sensing technologies for the broad field of life science research, providing unprecedented insight into the structure and function of individual bio-molecules under physiological conditions. Our ultimate goal is to develop hybrid materials of functionalized nanodiamonds that harness complex quantum dynamics at room temperature to observe biological processes down to the quantum level and with atomic resolution.

ERC Synergy Grant “BIOQ - Diamond Quantum Devices and Biology”
T. Weil (11 out of more than 750 projects)

BIOQ will create novel sensing technologies for the broad field of life science research, providing unprecedented insight into the structure and function of individual bio-molecules under physiological conditions. Our ultimate goal is to develop hybrid materials of functionalized nanodiamonds that harness complex quantum dynamics at room temperature to observe biological processes down to the quantum level and with atomic resolution.

The consortium investigates the microbial involvement in the development of Alzheimer’s Disease (AD) with the aim of microbiome modulation to slow down or halt its onset. This paves the road to new indirect diagnostic and therapeutic approaches for AD prevention, based on gut microbiota modulation through delivery of probiotic cocktails.

Horizon2020 “AD Gut” Alzheimer Disease - gut connection.
J. Quambusch, T. Weil

The consortium investigates the microbial involvement in the development of Alzheimer’s Disease (AD) with the aim of microbiome modulation to slow down or halt its onset. This paves the road to new indirect diagnostic and therapeutic approaches for AD prevention, based on gut microbiota modulation through delivery of probiotic cocktails.

 
loading content